A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

Keith J. Horvath, Sara Lammert, Richard F. MacLehose, Thu Danh, Jason V. Baker, Adam Carrico

Research output: Contribution to journalArticle

Abstract

APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

Original languageEnglish (US)
JournalAIDS and Behavior
DOIs
StatePublished - Jan 1 2019

Fingerprint

Mobile Applications
HIV
Randomized Controlled Trials
Technology
Control Groups
Therapeutics

Keywords

  • Drug use
  • HIV/AIDS
  • Medication adherence
  • Mobile app

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants. / Horvath, Keith J.; Lammert, Sara; MacLehose, Richard F.; Danh, Thu; Baker, Jason V.; Carrico, Adam.

In: AIDS and Behavior, 01.01.2019.

Research output: Contribution to journalArticle

@article{37348b277d1c4653ad4c6511777a9044,
title = "A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants",
abstract = "APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82{\%}, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0{\%} vs. 77.2{\%}). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.",
keywords = "Drug use, HIV/AIDS, Medication adherence, Mobile app",
author = "Horvath, {Keith J.} and Sara Lammert and MacLehose, {Richard F.} and Thu Danh and Baker, {Jason V.} and Adam Carrico",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s10461-019-02597-3",
language = "English (US)",
journal = "AIDS and Behavior",
issn = "1090-7165",
publisher = "Springer New York",

}

TY - JOUR

T1 - A Pilot Study of a Mobile App to Support HIV Antiretroviral Therapy Adherence Among Men Who Have Sex with Men Who Use Stimulants

AU - Horvath, Keith J.

AU - Lammert, Sara

AU - MacLehose, Richard F.

AU - Danh, Thu

AU - Baker, Jason V.

AU - Carrico, Adam

PY - 2019/1/1

Y1 - 2019/1/1

N2 - APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

AB - APP+ is a theoretically-grounded mobile app intervention to improve antiretroviral (ART) adherence among men who have sex with men (MSM) who use stimulants. We assessed the feasibility and acceptability of APP+ in a six-month randomized controlled trial among a national sample of 90 MSM recruited online; secondarily, we examined changes in self-reported ART adherence by study arm. Retention at the final assessment was 82%, and acceptability ratings were comparable to other technology-based interventions. MSM in the APP+ group reported higher self-reported percentage ART adherence in the past 30 days at the four-month timepoint compared to a no-treatment control group (89.0% vs. 77.2%). However, once access to the app was removed after month four, group differences in ART adherence diminished by month six. APP+ may be a potentially promising intervention approach for MSM living with HIV who use stimulants but would require enhancements to optimize acceptability and demonstrate more sustained effects.

KW - Drug use

KW - HIV/AIDS

KW - Medication adherence

KW - Mobile app

UR - http://www.scopus.com/inward/record.url?scp=85068974965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068974965&partnerID=8YFLogxK

U2 - 10.1007/s10461-019-02597-3

DO - 10.1007/s10461-019-02597-3

M3 - Article

C2 - 31309348

AN - SCOPUS:85068974965

JO - AIDS and Behavior

JF - AIDS and Behavior

SN - 1090-7165

ER -